Status:
COMPLETED
Feasibility of ESWT Treatment in Post-stroke Patients With Triceps Sural Spasticity
Lead Sponsor:
Azienda USL Reggio Emilia - IRCCS
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective is to evaluate the feasibility of two different rehabilitation protocols that differed from the number of treatment sessions (1 session of ESWT versus 3 weekly sessions of ESWT), in...
Eligibility Criteria
Inclusion
- Adult patients of legal age
- Time elapsed since the stroke between 6 and 60 months
- Autonomous or supervised walking with or without aids
- Spasticity of the sural triceps\> 1 on the MAS scale
Exclusion
- Joint stiffness of the lower limbs due to other pathologies (ex orthopedic or rheumatological);
- Conditions that interfere with evaluation or collaboration in rehabilitation treatment (major psychiatric illnesses, clearly detectable cognitive deficits, severe pre-existing disabilities, sensory disturbances, etc.)
- Focal antispasmodic toxin treatments in the previous 3 months or phenolic blocks in the previous 9 months in the treatment region
- Treatments with central antispasmodic drugs with dosage modifications in the last week of starting treatment
- Individual neurorehabilitation treatments in progress
Key Trial Info
Start Date :
July 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 22 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05255549
Start Date
July 22 2021
End Date
July 22 2022
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Operational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia
Reggio Emilia, Emilia-Romagna, Italy, 42123